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ABSTRACT
Background: In the present study, we tried to clarify
whether nuclear hypersegmentation of peripheral
blood eosinophils is correlated with peripheral
eosinophil counts and/or the activity of atopic dermati-
tis (AD) in 79 patients.
Methods: We also compared the grades of skin
scores, peripheral eosinophil counts, the rate of hyper-
segmentation of eosinophils and serum eosinophil
cationic protein (ECP) concentrations in eight patients
before and after treatment.
Results: There was a positive correlation between the
skin scores of AD and peripheral eosinophil counts 
(P < 0.01), between the skin scores of AD and the
number of nuclear lobes of eosinophils (P < 0.01) and
between eosinophil counts and the number of nuclear
lobes of eosinophils when the number of nuclear lobes
of eosinophils was fewer than three (P < 0.01). A pos-
itive correlation was observed between serum ECP
concentrations and eosinophil counts and/or skin
scores of AD (P < 0.001). A negative correlation was
observed between serum ECP concentrations and the
number of nuclear lobes fewer than two (P < 0.05).
During therapy, peripheral eosinophil counts and 
the degree of hypersegmented eosinophils decreased 
significantly, and this was associated with recovery of
skin conditions, but not with serum ECP concentrations.
Conclusions: These results suggest that eosinophil
hypersegmentation may reflect activated eosinophils
and also that the observation of nuclear hypersegmen-
tation in peripheral blood eosinophils is useful to
recognize the disease activity of AD.
Key words: atopic dermatitis, eosinophils, nuclear
lobes of eosinophils.
INTRODUCTION
Blood eosinophilia is associated with atopic dermatitis
(AD). Although the role of eosinophils in the pathogene-
sis of AD is not fully understood, it has been reported that
a relationship exists between the activation of eosinophils
and the severity of the skin lesions in AD.1 However, little
information is available about the nuclear segmentation
of eosinophils under pathologic conditions. According to
Sparrevohn and Wulff,2 the ‘lobe index’ in normal sub-
jects is 2.06 with 70–90% of bilobed eosinophils; the
remainder were either unsegmented or three-lobed,
while four-lobed nuclei were rarely encountered.
Recently, Chihara and Nakajima found that hyperseg-
mented eosinophils are present in the bronchoalveolar
lavage fluid of patients with pulmonary eosinophilia and
they also found that hypersegmented eosinophils are the
activated ones.3 These observations led us to speculate
that the presence of hypersegmented eosinophils may
reflect the disease activity of AD. We therefore tried 
to clarify whether the number of nuclear lobes of
eosinophils is correlated with the total number of periph-
eral blood eosinophils and/or the disease activity of AD.
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METHODS
Clinical specimens (n = 87) were obtained from 79
patients with AD (Table 1). Eight subjects (aged 0.4–0.9
years; mean (±SD) age 0.7 ± 0.2 years; six boys and two
girls) were longitudinally studied to clarify the changes in
the skin scores of AD, peripheral eosinophil counts, the
degree of hypersegmented eosinophils and serum
eosinophil cationic protein (ECP) concentrations before
and after treatment. The patients had no other allergic dis-
orders, such as allergic rhinitis or bronchial asthma. The
diagnosis of AD was made according to the criteria of
Hanifin and Rajka.4 None of the subjects received sys-
temic or topical steroids. Informed parental consent was
obtained. Grading scores of AD were assessed by the
scoring system proposed by Kimata and Igarashi.5 Briefly,
the grading of the skin scores was 0–2 in ascending order
of severity with respect to inflammation, lichenification
and cracking, respectively. These signs were assessed on
four areas of the body, namely the face, trunk, arms and
legs, and the maximum possible score was 24. Scores for
itching and sleep disturbance were graded 0–3 in ascend-
ing order of severity. The grading of skin scores was 0–30
(mild, ≤ 10; medium, 11–20; severe, > 21).
Peripheral blood samples were used to calculate
white blood cell counts, nuclear lobes of eosinophils,
serum ECP and IgE concentrations. White blood cell
counts were determined using an autoanalyzer (F820;
Sysmex, Kobe, Japan). Blood smears were stained using
the May–Grünwald–Giemsa method and the nuclear
lobes of 50–100 eosinophils were counted. The criteria
used for the number of nuclear lobes was as described
previously.6 All preparations were counted separately by
two authors (AY and TK). For each patient, the percent-
age of nuclear lobes per total numbers was calculated
as follows: (i) one- and two-lobed eosinophils; (ii) 
three-lobed eosinophils; and (iii) four- and five-lobed
eosinophils. There were no eosinophils with more than
six nuclear lobes. Serum samples were obtained by
using an SST tube (Becton Dickinson Biosciences, San
Jose, CA, USA). Serum ECP and IgE concentrations were
determined by radioimmunoassay (RIA; Amersham
Pharmacia Biotech UK, Little Chalfont, Buckinghamshire,
UK).
All data are expressed as the mean±SD. Statistical
analysis was performed using logistic regression analysis,
Pearson’s correlation coefficient and paired t-test.
RESULTS
There was a positive correlation between the skin scores
of AD and peripheral eosinophil counts (r = 0.564; P <
0.01). A positive correlation was observed between the
skin scores of AD and one- and two-lobed eosinophils 
(r = 0.426; P < 0.01; Fig. 1a), thee-lobed eosinophils 
(r = 0.313; P < 0.01; Fig. 1b) and four- and five-lobed
Table 1 Characteristics of patients with atopic dermatitis
No. patients (males/females) 79 (52/27)
Age (years) 1.3 ± 0.9 (0.4–4.0)
Serum IgE (IU/L) 201 ± 418 (10–2600)
Skin scores 10.3 ± 5.0 (3–21)
Peripheral eosinophil counts 575 ± 492 (113–2490)
Data are presented as the mean ± SD, with the range given in
parentheses.
Fig. 1 (a) Relationship between one- and two-lobed eosinophils and the skin scores of atopic dermatitis (AD; P < 0.01). The
horizontal axis shows one- and two-lobed eosinophils; the vertical axis shows the skin scores of AD (mild, moderate and severe). The
area under the lower curve is the region of mild AD. The area between the two curves is a region of moderate AD. The area over
the upper curve is the region of severe AD. (b) Relationship between three-lobed eosinophils and the skin scores of AD (P < 0.01).
(c) Relationship between four- and five-lobed eosinophils and the skin scores of AD (P < 0.01).
eosinophils (r = 0.475; P < 0.01; Fig. 1c). A positive
correlation was observed between peripheral eosinophil
counts and three-lobed eosinophils (r = 0.359; Fig. 2b).
There was a negative correlation between peripheral
eosinophil counts and one- and two-lobed eosinophils 
(r = 0.371; Fig. 2a). However, there was no correlation
between peripheral eosinophil counts and four- and 
five-lobed eosinophils (Fig. 2c). There was a negative
correlation between one- and two-lobed eosinophils and
three-lobed eosinophils or four- and five-lobed
eosinophils (r = 0.91 or r = 0.21; Fig. 3a,b). There was
no correlation between three-lobed eosinophils and
four- and five-lobed eosinophils (Fig. 3c). There was a
positive correlation between serum ECP concentrations
and the skin scores of AD and/or peripheral eosinophil
counts (r = 0.546, r = 0.774, respectively; P < 0.01).
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Fig. 3 (a,b) Relationship between one- and two-lobed and three-lobed (P < 0.01) or four- and five- lobed eosinophils (P < 0.05).
(c) Relationship between three-lobed and four- and five-lobed eosinophils.
Fig. 2 (a) Relationship between one- and two-lobed eosinophils and peripheral eosinophil counts (P < 0.01). (b) Relationship
between three-lobed eosinophils and peripheral eosinophil counts (P < 0.01). (c) Relationship between four- and five-lobed
eosinophils and peripheral eosinophil counts.
There was a weak negative correlation between serum
ECP levels and one- and two-lobed eosinophils 
(P < 0.05; Fig. 4).
We compared changes in the skin scores of AD,
peripheral eosinophil counts, the degree of hyper-
segmented eosinophils and serum ECP concentrations at
before and after the treatment for 1 month in the eight
patients (Fig. 5). Skin scores of AD, one- and two- lobed
eosinophils and three-lobed eosinophils dramatically
decreased after treatment (P < 0.01). Peripheral
eosinophil counts decreased slightly (P < 0.05). There
was no difference in serum ECP concentrations and
three-lobed eosinophils between before and after
treatment.
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Fig. 5 Changes in (a) one- and two-lobed, (b) three-lobed and (c) four- and five-lobed eosinophils before and after treatment.
Changes in (d) the skin scores of atopic dermatitis (AD), (e) peripheral eosinophil counts and (f) serum eosinophil cationic protein
(ECP) concentrations before and after treatment.
Fig. 4 Relationship between one- and two-lobed eosinophils
and serum eosinophil cationic protein (ECP) concentrations 
(P < 0.05).
DISCUSSION
Eosinophils may be of major relevance in the pathogene-
sis of AD, because patients with AD frequently show
raised blood eosinophil counts. However, the diagnostic
importance of this finding has been unclear and a matter
of speculation.7 Uehara et al. demonstrated that some
severe cases of AD show a normal eosinophil level.7 In
the present study, we found that there was a good corre-
lation between peripheral eosinophil counts, especially
an increase of hypersegmented eosinophils, and the skin
scores of AD. We also described that an increase of
peripheral eosinophil counts did not always reflect an
increase of hypersegmented eosinophils. These findings
suggest that the presence of hypersegmented eosinophils
does not always reflect the occurence of eosinophilia.
Toxic proteins, such as major basic protein (MBP) or
ECP, are contained in the matrix and core of secondary
granules of eosinophils and are considered to play an
important role in the propagation of the allergic inflam-
matory process. Recently, Leiferman et al. reported that
significant deposits of eosinophil-derived MBP in the
eczematous skin could be a sign of eosinophil degranu-
lation at the site of inflammation and also described a
possible correlation between disease activity and the
deposition of eosinophil granule contents.8,9 It is well
known that serum ECP levels may be useful to monitor the
disease activity of AD.10 Eosinophil cationic protein does
not represent a simple measure of blood eosinophilia.1 It
seems likely that increased ECP levels may reflect the acti-
vation state of the whole eosinophil pool. In the present
study, serum ECP levels did not change during treatment,
although the number of hypersegmented eosinophils
decreased with recovery of AD during the 1 month treat-
ment period. In contrast, a good correlation was
observed between serum ECP levels and peripheral
eosinophil counts or skin scores of AD in all cases. These
results suggest that serum ECP levels do not fully reflect
the disease severity of AD after 1 month treatment and
that the change in numbers of hypersegmented
eosinophils may be a more sensitive marker to reflect the
disease activity of AD.
Chihara and Nakajima demonstrated that nuclear
hypersegmentation of eosinophils could be produced by
stimulation with eosinophil chemotactic factor and/or
certain lymphokines.3 Their report suggests that hyper-
segmented eosinophils are activated ones produced by
inflammatory cytokines. In addition to the above observa-
tions, we found a lack of correlation between peripheral
blood eosinophil counts and the number of nuclear lobes
of peripheral blood eosinophils. If Arneth’s hypothesis is
correct,2,11 the eosinophil ‘shift to the right’ reflects an
increased average of blood eosinophils.2 However, our
data suggest that the physiological phenomenon of ‘shift
to the right’ is completely different between neutrophils
and eosinophils. The mechanism of eosinophil activation
and feedback could be considered as follows: (i)
eosinophil chemotactic activity (ECA) and cytokines are
produced and released from lymphocytes or basophilic
cells by certain antigen stimulation; (ii) as ECA enters the
circulating pool, a concentration gradient is produced
between a target organ and peripheral blood; (iii) in
response to this gradient, activated eosinophils are
attracted to the target organ, leading to a transient
decrease in peripheral blood eosinophils, although acti-
vated eosinophils may still be present in the circulating
pool; and (iv) finally, the feedback mechanism and pro-
duction of eosinophil-activating factors, such as
interleukin (IL)-3 and/or IL-5, by lymphocytes is accere-
lated, resulting in eosinophilia. Thus, the changes of
blood eosinophil and/or activated eosinophil counts may
be regulated. This hypothesis about eosinophil regulation
may clearly explain our data. It seems likely that activated
and hypersegmented eosinophils move to the target
organ from the circulating pool, resulting in a decrease in
peripheral eosinophil counts.
In conclusion, the observation of nuclear segmentation
of blood eosinophils may be useful to recognize the
disease activity of AD.
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